Ranirestat

Results: 1



#Item
1Special Feature Innovation New Opportunities in Regenerative Medicine & Cell Therapy In its third Mid-term Business Plan (the 3rd MTBP), Sumitomo Dainippon Pharma points to

Special Feature Innovation New Opportunities in Regenerative Medicine & Cell Therapy In its third Mid-term Business Plan (the 3rd MTBP), Sumitomo Dainippon Pharma points to

Add to Reading List

Source URL: www.ds-pharma.com

Language: English - Date: 2014-11-05 02:10:52